HAVLF HAVN LIFE SCIENCES INC

HAVN Life Closes First Tranche Of July Financing By ABO, Details On Amendments And Debt Shares Issuance

Biotech psychedelics company HAVN Life Sciences Inc. (OTC:HAVLF) recently closed the initial tranche of its financing pact with innovative fund Alpha Blue Ocean ("ABO"), previously announced on July 2

08-20-2022 04:10:13

HAVN Life Sciences announces 1-for-30 reverse stock split

HAVN Life Sciences (OTCPK:HAVLF) announced Friday the reverse stock split at 1-for-30 of its shares.  Stock will begin trading on a consolidated basis on August 3, ‎‎2022, with a new CUSIP number. As

07-30-2022 05:01:09

HAVN Life Announces a 30:1 Consolidation of its Common Shares

VANCOUVER, British Columbia, July 29, 2022 (GLOBE NEWSWIRE) -- HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") a biotechnology company pursuing standardize

07-30-2022 04:35:31

HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details

Two publicly traded psychedelics companies announced supply agreements. HAVN Life Sciences (OTC:HAVLF) will provide mental health clinic MPB Group Inc. with psilocybin-containing mushrooms for its the

06-29-2022 03:30:12

HAVN Life enters supply agreement with MPB Group

HAVN Life Sciences (OTCPK:HAVLF) enters into a supply partnership with a comprehensive outpatient mental health clinic, MPB Group. MPB Group is partnered with Healing Escapes Foundation retreats, a n

06-28-2022 19:39:15

HAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022

VANCOUVER, BC / ACCESSWIRE / April 30, 2022 / HAVN Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) (FSE:5NP), a biotechnology company pursuing standardized extraction of psychedelic compounds for investigat

04-30-2022 20:07:22

HAVN Life expands supply agreement with Mycotopia Therapies

HAVN Life Sciences (OTCPK:HAVLF) has expanded its supply partnership with Mycotopia Therapies, adding a second supply agreement that covers functional mushrooms, HAVN Life's recently launched natural

03-22-2022 21:14:49

HAVN Life Enters Distribution Agreement With Mycrodose Therapeutics For U.S. Market

HAVN Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) (FSE: 5NP), a biotechnology company working with psychedelic compounds for investigational research to support brain health and cognitive function, annou

02-11-2022 11:06:07

Havn Life Buys Subscription-Based Functional Mushroom Co. With Significant US Consumer Base

Biotech company Havn Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) is purchasing functional mushroom wellness brand Spore Life Sciences Inc. The Deal Details Under the deal between HAVN Life, its newly i

12-21-2021 03:52:31

HAVN Life Successfully Exports Naturally Derived Psilocybin From Its Jamaica Facility Into Canada

Demonstrating the integrity of its supply chain from Jamaica into Canada, biotechnology company HAVN Life Sciences (OTCPK: HAVLF) achieved a milestone with international delivery - not an easy task. M

11-24-2021 03:26:05